Nuvation Bio Inc. Shares Outstanding (Cover Page)
Nuvation Bio Inc. (NUVB) had Shares Outstanding (Cover Page) of 351.12 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 351.12M shares.
- 2026-04-29: Entity Common Stock, Shares Outstanding 348.20M shares.
- 2025-10-24: Entity Common Stock, Shares Outstanding 342.83M shares.
- 2025-07-31: Entity Common Stock, Shares Outstanding 342.27M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 351.12M shares 10-Q · filed 2026-08-06 |
| 2026-04-29 | 348.20M shares 10-Q · filed 2026-05-04 |
| 2025-10-24 | 342.83M shares 10-Q · filed 2025-11-03 |
| 2025-07-31 | 342.27M shares 10-Q · filed 2025-08-07 |
| 2025-04-25 | 340.26M shares 10-Q · filed 2025-05-07 |
| 2024-10-25 | 336.57M shares 10-Q · filed 2024-11-06 |
| 2024-07-29 | 249.25M shares 10-Q · filed 2024-08-05 |
| 2024-04-30 | 247.17M shares 10-Q · filed 2024-05-14 |
| 2023-10-27 | 218.94M shares 10-Q · filed 2023-11-02 |
| 2023-07-28 | 218.94M shares 10-Q · filed 2023-08-03 |
| 2023-04-28 | 218.80M shares 10-Q · filed 2023-05-04 |
| 2022-10-28 | 218.39M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 218.24M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 218.14M shares 10-Q · filed 2022-05-09 |
| 2021-10-29 | 217.79M shares 10-Q · filed 2021-11-10 |
| 2021-07-30 | 217.76M shares 10-Q · filed 2021-08-12 |
| 2021-04-30 | 217.65M shares 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |